{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:07:46Z","timestamp":1790273266793,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002649","name":"Yeungnam University","doi-asserted-by":"publisher","award":["220A380070"],"award-info":[{"award-number":["220A380070"]}],"id":[{"id":"10.13039\/501100002649","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.118080","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T19:10:53Z","timestamp":1594321853000},"page":"118080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations"],"prefix":"10.1016","volume":"257","author":[{"given":"Shiv","family":"Bharadwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek Dhar","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2020.118080_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118080_bb0010","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"issue":"18","key":"10.1016\/j.lfs.2020.118080_bb0015","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1111\/febs.12936","article-title":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design","volume":"281","author":"Hilgenfeld","year":"2014","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.lfs.2020.118080_bb0020","doi-asserted-by":"crossref","first-page":"e13209","DOI":"10.1111\/eci.13209","article-title":"The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm","volume":"50","author":"Bassetti","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.lfs.2020.118080_bb0025","series-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","first-page":"1928","article-title":"Coronaviruses, including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)","volume":"vol. e2","author":"McIntosh","year":"2015"},{"issue":"5","key":"10.1016\/j.lfs.2020.118080_bb0030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2020.118080_bb0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"7798","key":"10.1016\/j.lfs.2020.118080_bb0040","first-page":"270","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"579","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.lfs.2020.118080_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41579-020-0332-0","article-title":"Outbreak of a novel coronavirus","volume":"18","author":"du Toit","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118080_bb0050","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.lfs.2020.118080_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2020.118080_bb0060","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","article-title":"An overview of severe acute respiratory syndrome\u2013coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy","volume":"59","author":"Pillaiyar","year":"2016","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2020.118080_bb0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses-drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6489","key":"10.1016\/j.lfs.2020.118080_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.lfs.2020.118080_bb0075","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2020.118080_bb0080","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"ChemBioChem"},{"issue":"6","key":"10.1016\/j.lfs.2020.118080_bb0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2020.118080_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s13238-013-2841-3","article-title":"The newly emerged SARS-like coronavirus HCoV-EMC also has an \u201cAchilles\u2019 heel\u201d: current effective inhibitor targeting a 3C-like protease","volume":"4","author":"Ren","year":"2013","journal-title":"Protein Cell"},{"issue":"10","key":"10.1016\/j.lfs.2020.118080_bb0095","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.lfs.2020.118080_bb0100","series-title":"Cancer Bioinformatics","first-page":"243","article-title":"In silico oncology drug repositioning and polypharmacology","author":"Cheng","year":"2019"},{"issue":"28","key":"10.1016\/j.lfs.2020.118080_bb0105","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.2174\/0929867325666180530100332","article-title":"Computational drug repurposing: current trends","volume":"26","author":"Karaman","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2020.118080_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.drudis.2016.09.019","article-title":"Design of efficient computational workflows for in silico drug repurposing","volume":"22","author":"Vanhaelen","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.lfs.2020.118080_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5530\/jyp.2019.11.26","article-title":"Drug repurposing in antiviral research: a current scenario","volume":"11","author":"Mani","year":"2019","journal-title":"J Young Pharm."},{"issue":"8","key":"10.1016\/j.lfs.2020.118080_bb0120","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"18","key":"10.1016\/j.lfs.2020.118080_bb0125","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40265-017-0830-1","article-title":"Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies","volume":"77","author":"Dyall","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2020.118080_bb0130","doi-asserted-by":"crossref","first-page":"e2644","DOI":"10.1002\/jmr.2644","article-title":"Computational modeling of the bat HKU4 coronavirus 3CLpro inhibitors as a tool for the development of antivirals against the emerging Middle East respiratory syndrome (MERS) coronavirus","volume":"30","author":"Abuhammad","year":"2017","journal-title":"J. Mol. Recognit."},{"issue":"22","key":"10.1016\/j.lfs.2020.118080_bb0135","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jm0501782","article-title":"A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods","volume":"48","author":"Kaeppler","year":"2005","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.lfs.2020.118080_bb0140","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1021\/bi0361766","article-title":"Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro","volume":"43","author":"Bacha","year":"2004","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.lfs.2020.118080_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.lfs.2020.118080_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118080_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.lfs.2020.118080_bb0160","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00594-16","article-title":"rRNA binding sites and the molecular mechanism of action of the tetracyclines","volume":"60","author":"Chukwudi","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.lfs.2020.118080_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126360","article-title":"A combination of doxycycline and ribavirin alleviated chikungunya infection","volume":"10","author":"Rothan","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lfs.2020.118080_bb0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1358\/mf.1998.20.8.487489","article-title":"Antimurine retroviral effect of doxycycline","volume":"20","author":"Sturtz","year":"1998","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118080_bb0175","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00705-013-1880-7","article-title":"Inhibitory effect of doxycycline against dengue virus replication in vitro","volume":"159","author":"Rothan","year":"2014","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118080_bb0180","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1371\/journal.pone.0000428","article-title":"Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors","volume":"2","author":"Yang","year":"2007","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lfs.2020.118080_bb0185","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkm307","article-title":"Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells","volume":"60","author":"Michaelis","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.lfs.2020.118080_bb0190","series-title":"Antiviral Compounds and Methods of Using Thereof U.S. Patent 7,999,001","author":"Aman","year":"2011"},{"issue":"5","key":"10.1016\/j.lfs.2020.118080_bb0195","first-page":"284","article-title":"A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia","volume":"10","author":"Si","year":"2004","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118080_bb0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/bcpt.12444","article-title":"Is minocycline an antiviral agent? A review of current literature","volume":"118","author":"Nagarakanti","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118080_bb0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/phar.2395","article-title":"Therapeutic potential for tetracyclines in the treatment of COVID-19","volume":"40","author":"Sodhi","year":"2020","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"issue":"6","key":"10.1016\/j.lfs.2020.118080_bb0210","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1021\/acs.jcim.0c00179","article-title":"Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study","volume":"60","author":"Wang","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.lfs.2020.118080_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M pro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.lfs.2020.118080_bb0220","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera - a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2020.118080_bb0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2020.118080_bb0230","series-title":"SC'06: Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing","first-page":"43","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"issue":"1","key":"10.1016\/j.lfs.2020.118080_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-55723-5","article-title":"Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease","volume":"9","author":"Bharadwaj","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118080_bb0240","first-page":"1","article-title":"Structure-based screening and validation of bioactive compounds as Zika virus methyltransferase (MTase) inhibitors through first-principle density functional theory, classical molecular simulation and QM\/MM affinity estimation","author":"Bharadwaj","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.lfs.2020.118080_bb0245","first-page":"1","article-title":"Design and molecular dynamic investigations of 7,8-dihydroxyflavone derivatives as potential neuroprotective agents against alpha-synuclein","volume":"10","author":"Thangavel","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118080_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir. Res."},{"issue":"10238","key":"10.1016\/j.lfs.2020.118080_bb0255","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:19:43Z","timestamp":1765228783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520308316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":51,"alternative-id":["S0024320520308316"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118080","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118080"}}